We are live on ! Find out more
LPIC

LeJeune Puetz Investment Counsel Portfolio holdings

AUM $279M
1-Year Est. Return 4.39%
This Fund
S&P 500
This Quarter Est. Return
-3.91%
1 Year Est. Return
-4.39%
3 Year Est. Return
+64.06%
5 Year Est. Return
+61.21%
10 Year Est. Return
–
AUM
$286M
AUM Growth
-$10.3M
Cap. Flow
+$4.34M
Cap. Flow %
1.52%
Top 10 Hldgs %
27.47%
Holding
200
New
5
Increased
61
Reduced
36
Closed
8

Top Buys

Rank Stock Value
1
VBR icon
Vanguard Morningstar Small-Cap Value ETF
VBR
+$501K
2
GS icon
Goldman Sachs
GS
+$482K
3
JNJ icon
Johnson & Johnson
JNJ
+$460K
4
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$433K
5
AMZN icon
Amazon
AMZN
+$399K

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$613K
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$544K
3
MCD icon
McDonald's
MCD
+$187K
4
BP icon
BP
BP
+$170K
5
CRWD icon
CrowdStrike
CRWD
+$164K

Sector Composition

Rank Sector Weight
1 Technology 14.83%
2 Healthcare 11.02%
3 Financials 8.11%
4 Consumer Discretionary 7.08%
5 Communication Services 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSLA icon
176
Tesla
TSLA
$1.29T
$129K 0.05%
360
– –
TTC icon
177
Toro Company
TTC
$9.32B
$127K 0.04%
1,490
– –
IYG icon
178
iShares US Financial Services ETF
IYG
$2.22B
$119K 0.04%
1,986
-450
-18% -$28.4K
WEC icon
179
WEC Energy
WEC
$35.6B
$114K 0.04%
1,151
– –
MHD icon
180
BlackRock MuniHoldings Fund
MHD
$604M
$113K 0.04%
7,961
– –
GLD icon
181
SPDR Gold Trust
GLD
$144B
$112K 0.04%
625
– –
MACK
182
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$112K 0.04%
2,200
-1,400
-39% -$7.87K
IBB icon
183
iShares Biotechnology ETF
IBB
$9.86B
$108K 0.04%
830
– –
IEFA icon
184
iShares Core MSCI EAFE ETF
IEFA
$196B
$107K 0.04%
1,550
– –
IOO icon
185
iShares Global 100 ETF
IOO
$9.43B
$106K 0.04%
+1,400
New +$105K
NEE icon
186
NextEra Energy
NEE
$179B
$101K 0.04%
1,200
-899
-43% -$72K
BIIB icon
187
Biogen
BIIB
$30.9B
– –
-452
Closed -$108K
CCI icon
188
Crown Castle
CCI
$31.5B
– –
-515
Closed -$108K
CRM icon
189
Salesforce
CRM
$158B
– –
-434
Closed -$110K
CRWD icon
190
CrowdStrike
CRWD
$226B
– –
-3,200
Closed -$164K
IAT icon
191
iShares US Regional Banks ETF
IAT
$687M
– –
-1,820
Closed -$112K
SBUX icon
192
Starbucks
SBUX
$124B
– –
-971
Closed -$114K
VGT icon
193
Vanguard Information Technology ETF
VGT
$149B
– –
-1,760
Closed -$101K
BHVN
194
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-3,950
Closed -$544K
4 5 6 7
8

Similar funds

HAM
Hao Advisors Management Hong Kong $289M AUM
SWM
Southern Wealth Management Dallas, Texas $258M AUM 8.53% 1-Year Est. Return
BAM
Baldrige Asset Management Allentown, Pennsylvania $244M AUM 5.81% 1-Year Est. Return
CPWMP
Cardinal Point Wealth Management Partners Irvine, California $329M AUM 6.55% 1-Year Est. Return
CCM
Chimera Capital Management New York $210M AUM 21.21% 1-Year Est. Return
AIP
Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return
HC
HNP Capital Rochester, New York $359M AUM 3.18% 1-Year Est. Return
AFM
Andesa Financial Management Allentown, Pennsylvania $195M AUM 2.34% 1-Year Est. Return

LeJeune Puetz Investment Counsel's Q1 2022 Portfolio in Review

As of Q1 2022, LeJeune Puetz Investment Counsel held 200 positions worth $286M, down 3.5% from $297M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

LeJeune Puetz Investment Counsel's Q1 2022 filing shows 5 new, 61 increased, 36 reduced and 8 closed positions. Its largest new stake was CONSTELLATION ENRGY GP(HLDG CO: 6,816 shares worth $383K. The largest sale was Exelon, an estimated $613K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • LeJeune Puetz Investment Counsel's largest Q1 2022 buy was CONSTELLATION ENRGY GP(HLDG CO: 6,816 shares worth $383K.
  • LeJeune Puetz Investment Counsel added most to Vanguard Morningstar Small-Cap Value ETF in Q1 2022, an estimated $501K increase.
  • LeJeune Puetz Investment Counsel's biggest Q1 2022 reduction was Exelon, cutting an estimated $613K.
  • LeJeune Puetz Investment Counsel fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q1 2022, selling an estimated $544K.
  • LeJeune Puetz Investment Counsel's ten largest holdings make up 27% of its $286M portfolio in Q1 2022.
  • LeJeune Puetz Investment Counsel opened 5 new positions and closed 8 in Q1 2022.
  • LeJeune Puetz Investment Counsel's portfolio value fell 3.5% quarter-over-quarter to $286M.

Based on LeJeune Puetz Investment Counsel's 13F filing for Q1 2022, filed 2 May 2022.